Tianda Pharmaceuticals Limited (Hong Kong SAR, China)

Tianda Pharmaceuticals Limited is a Hong Kong-listed company (stock code 0455) that focuses on the development of traditional Chinese medicine and innovative drugs, as well as healthcare services. The company aims to become a competitive pharmaceutical enterprise with a strong market presence and a core value chain in drug development, medical technology, traditional Chinese medicine diagnosis, and health management. Tianda Pharmaceuticals has established a complete industry chain for traditional Chinese medicine, including Chinese medicine, traditional Chinese medicine intelligence, and the creation of the "Tianda Standard" to control the quality of Chinese medicinal materials. The company has also founded a new type of Chinese medicine clinic called "Tianda Hall." As a platform for traditional Chinese medicine diagnosis and health management, Tianda Hall adheres to the concept of "treating the disease before it occurs" and the treatment principle of "stopping treatment when the disease is cured, focusing on the patient." The company aims to become the leading brand in Chinese medicine clinics, with a presence in the Greater Bay Area of Guangdong, Hong Kong, and Macau, as well as nationwide and globally. Tianda Pharmaceuticals utilizes internet technology, big data, artificial intelligence, and other innovative technologies to establish the "Cloud Tianda Hall," integrating online and offline traditional Chinese medicine services, remote diagnosis, and expert consultations, providing high-quality, convenient, and comprehensive traditional Chinese medicine healthcare services to the public and leading the promotion of traditional Chinese medicine inheritance, innovation, and development. Tianda Pharmaceuticals focuses on the global development and latest achievements in medical and health technology, increasing research and development investment, enhancing innovation, accelerating technological progress, optimizing product structure, and improving service levels to establish sustainable competitive advantages. The company's product portfolio includes Chinese medicine, chemical drugs, biological products, health products, and medical devices, covering various therapeutic areas such as cardiovascular, pediatrics, cold and respiratory systems, anti-infection, anti-addiction, anti-tumor, and others. The company also offers health products under the "He Gu" and "Tuo Kang" brands. With China as its foundation, Tianda Pharmaceuticals strives to expand into international markets and build a global marketing network. The company has established marketing centers in Shenzhen and Zhuhai, responsible for sales and brand building in the Chinese market. Through distributors and retailers in various provinces and cities, the company's products are sold nationwide. Tianda Pharmaceuticals has wholly-owned subsidiaries in Hong Kong and Australia, and is gradually establishing branches in the United States and Europe to handle sales and brand building in Hong Kong, Macau, Australia, and international markets. Driven by market demand, Tianda Pharmaceuticals expands its medical and healthcare services, collaborates with high-quality domestic and international partners, integrates advanced treatment and healthcare technologies, and establishes a global health examination, health management, health consultation, and chronic disease prevention and control system to meet the growing and diverse medical and healthcare needs and better safeguard the health and well-being of the general public. The company's vision slogan is "Your Health is Our Priority!" which expresses Tianda Pharmaceuticals' desire and pursuit to continuously contribute to health and care. With this as its driving force, Tianda Pharmaceuticals strives to become a leading pharmaceutical enterprise rooted in China and radiating globally.